Follow the 안국약품 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 안국약품 has recorded 17 public disclosures. The latest transaction was filed on 30 June 2026 (Other). Among the most active insiders: 어진. All data is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
17 of 17 declarations
안국약품 is a South Korean company specializing in the manufacture of pharmaceutical products. It is listed on the XKRX market.